-+ 0.00%
-+ 0.00%
-+ 0.00%

Guangzhou Pharmaceutical, affiliated with Baiyunshan (00874), plans to introduce strategic investors through capital increases and stock expansion, and is expected to raise 1 billion to 3 billion yuan

Zhitongcaijing·07/10/2026 10:41:04
Listen to the news

Zhitong Finance App News, Baiyunshan (00874) announced that Guangzhou Pharmaceutical, a subsidiary of the company, plans to introduce strategic investors through capital increases and stock expansion. Guangzhou Pharmaceutical will issue no more than 920 million shares in this capital increase. The total amount of capital raised is estimated to be between RMB 1 billion (including RMB 1 billion) and RMB 3 billion (including RMB 3 billion).

Guangzhou Pharmaceutical introduces strategic investors through capital increases and stock expansion, which can meet the capital needs of Guangzhou Pharmaceutical's business development and subsequent operations, help it relieve pressure on liquidity, optimize asset liquidity levels, enhance its ability to withstand financial risks, further enhance its overall comprehensive competitiveness, and conform to the Group's overall strategic plan and the overall interests of the company and shareholders.